申请人:Mitsui Toatsu Chemicals, Inc.
公开号:US05627193A1
公开(公告)日:1997-05-06
The present invention relates to quinoline-4-carbonylguanidine derivative represented by formula (1) ##STR1## and pharmaceutically acceptable salt thereof, a process for producing the same, and a Na.sup.+ /H.sup.+ exchanger inhibitor containing the compound as an active ingredient. The compounds of the present invention are useful as an agent for treating or preventing various diseases by hyperfunction of the Na.sup.+ /H.sup.+ exchanger and as a diagnostic agent for these diseases.
本发明涉及由式(1)所代表的喹啉-4-羰基胍衍生物及其药学上可接受的盐,制备该化合物的方法,以及含有该化合物作为活性成分的Na.sup.+ /H.sup.+交换抑制剂。本发明的化合物可用作治疗或预防由Na.sup.+ /H.sup.+交换器的高功能引起的各种疾病的药剂,以及用于这些疾病的诊断剂。